149 related articles for article (PubMed ID: 474434)
1. Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure.
Elkayam U; Lejemtel TH; Mathur M; Ribner HS; Frishman WH; Strom J; Sonnenblick EH
Am J Cardiol; 1979 Sep; 44(3):540-5. PubMed ID: 474434
[No Abstract] [Full Text] [Related]
2. Comparative hemodynamic effects of intravenous nitroprusside and oral prazosin in refractory heart failure.
Mehta J; Iacona M; Feldman RL; Pepine CJ; Conti CR
Am J Cardiol; 1978 May; 41(5):925-30. PubMed ID: 645603
[No Abstract] [Full Text] [Related]
3. Development of pharmacodynamic tolerance to prozosin in congestive heart failure.
Desch CE; Magorien RD; Triffon DW; Blanford MF; Unverferth DV; Leier CV
Am J Cardiol; 1979 Nov; 44(6):1178-82. PubMed ID: 495512
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of prazosin effect on cardiac output in chronic heart failure.
Arnold SB; Williams RL; Ports TA; Baughman RA; Benet LZ; Parmley WW; Chatterjee K
Ann Intern Med; 1979 Sep; 91(3):345-9. PubMed ID: 475164
[TBL] [Abstract][Full Text] [Related]
5. Acute and chronic cardiocirculatory effects of oral prazosin in chronic refractory heart failure.
Hayashi H; Sassa H; Oba M; Fukaya T; Okubo M; Niwa T; Matsui E
Jpn Heart J; 1980 Nov; 21(6):827-36. PubMed ID: 7007686
[TBL] [Abstract][Full Text] [Related]
6. [Vasodilator therapy with prazosin for severe congestive heart failure--hemodynamic effects of oral single administration and chronic use (author's transl)].
Akamatsu T; Suzuki A; Yamamoto T; Takahashi S; Kimata S; Hirosawa K
Kokyu To Junkan; 1979 Sep; 27(9):991-7. PubMed ID: 538350
[No Abstract] [Full Text] [Related]
7. Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.
Magorien RD; Triffon DW; Desch CE; Bay WH; Unverferth DV; Leier CV
Ann Intern Med; 1981 Jul; 95(1):5-13. PubMed ID: 7247126
[TBL] [Abstract][Full Text] [Related]
8. [The effects of prazosin in patients with chronic refractory heart failure-acute hemodynamic effects of oral prazosin and long-term therapy (author's transl)].
Honda T; Hiramori K; Haze K; Saito M; Fuseno H; Fukami K; Umemoto M; Tanaka N; Ikeda M
Kokyu To Junkan; 1981 May; 29(5):527-35. PubMed ID: 7313357
[No Abstract] [Full Text] [Related]
9. The acute and chronic haemodynamic effects of prazosin in severe congestive cardiac failure.
Harper RW; Claxton H; Middlebrook K; Anderson S; Pitt A
Med J Aust; 1980 Jul; 2(SP1):36-8. PubMed ID: 7421721
[No Abstract] [Full Text] [Related]
10. Serial hemodynamic studies during the treatment of congestive heart failure with isolated low-dose oral prazosin therapy.
Reyns PR; Romney D; Desser KB; Benchimol A
Angiology; 1979 Dec; 30(12):850-5. PubMed ID: 533015
[TBL] [Abstract][Full Text] [Related]
11. Use of oral prazosin hydrochloride in congestive failure following acute myocardial infarction.
Lopez-Sendon J; Coma-Canella I; Lombera F; Jadraque LM
Am Heart J; 1979 Oct; 98(4):495-504. PubMed ID: 484435
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography.
Awan NA; Miller RR; DeMaria AN; Maxwell KS; Neumann A; Mason DT
Circulation; 1977 Sep; 56(3):346-54. PubMed ID: 884789
[TBL] [Abstract][Full Text] [Related]
13. Beneficial hemodynamic response to chronic prazosin therapy in congestive heart failure.
Feldman RC; Ball RM; Winchester MA; Jaillon P; Kates RE; Harrison DC
Am Heart J; 1981 May; 101(5):534-40. PubMed ID: 7223593
[TBL] [Abstract][Full Text] [Related]
14. Paradox of improved exercise but not resting hemodynamics with short-term prazosin in chronic heart failure.
Rubin SA; Chatterjee K; Gelberg HJ; Ports TA; Brundage BH; Parmley WW
Am J Cardiol; 1979 Apr; 43(4):810-5. PubMed ID: 425918
[TBL] [Abstract][Full Text] [Related]
15. Influence of oral prazosin therapy on exercise hemodynamics in patients with severe chronic heart failure.
Chatterjee K; Rubin SA; Ports TA; Parmley WW
Am J Med; 1981 Jul; 71(1):140-6. PubMed ID: 7246571
[TBL] [Abstract][Full Text] [Related]
16. Dynamic responses to continuous use of prazosin and hydralazine in patients with refractory heart failure.
Elkayam U; Mathur M; Frishman W; LeJemtel T; Strom J; Sonnenblick EH
Clin Pharmacol Ther; 1981 Jul; 30(1):23-30. PubMed ID: 7237894
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive radiocardiographic assessment of the effects of prazosin in congestive heart failure.
Nakajima H; Yui Y; Kawashita K; Yoshida A; Kawai C
Jpn Circ J; 1982 May; 46(5):468-72. PubMed ID: 7077811
[TBL] [Abstract][Full Text] [Related]
18. Prazosin and congestive heart failure: short- and long-term therapy.
Rouleau JL; Warnica JW; Burgess JH
Am J Med; 1981 Jul; 71(1):147-52. PubMed ID: 7246572
[TBL] [Abstract][Full Text] [Related]
19. Cardiocirculatory effects of afterload reduction with oral trimazosin in severe chronic congestive heart failure.
Awan NA; Hermanovich J; Whitcomb C; Skinner P; Mason DT
Am J Cardiol; 1979 Jul; 44(1):126-31. PubMed ID: 453037
[TBL] [Abstract][Full Text] [Related]
20. Comparison of haemodynamic effects of oral hydralazine and prazosin hydrochloride in patients with chronic congestive heart failure.
Chatterjee K; Ports TA; Arnold S; Brundage B; Parmley W
Br Heart J; 1979 Dec; 42(6):657-63. PubMed ID: 534582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
